| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 1,035,269 | 1,086,567 | 1,141,656 | 1,366,925 | | Cost of Revenue | 617,278 | 652,184 | 679,476 | 814,353 | | | Gross Profit | 417,991 | 434,383 | 462,180 | 552,572 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 365,194 | 367,781 | 382,682 | 399,636 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 18,184 | 18,949 | 19,215 | 19,756 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 47,577 | 47,653 | 60,283 | 133,180 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,978 | 19 | 6 | 29 | | Earnings Before Interest And Taxes | 47,591 | 47,672 | 60,289 | 133,209 | | Interest Expense | 507 | 506 | 321 | 1,129 | | Income Before Tax | 47,084 | 47,166 | 59,968 | 132,080 | | Income Tax Expense | 16,828 | 18,550 | 23,658 | 50,273 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,256 | 28,616 | 36,310 | 81,807 | | | Non-recurring Events | | Discontinued Operations | 73 | (173) | (79) | (3,042) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,329 | 28,443 | 36,231 | 78,765 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,329 | $28,443 | $36,231 | $78,765 |
|
0.51% Nasdaq 
Income Statement
